Work

New Territory: Ethical Challenges Associated With MDMA-Assisted Psychotherapy for PTSD

Year: 2024

Type: article

Abstract: The present article explores ethical considerations related to 3,4-methylenedioxymethamphetamine (MDMA)–assisted therapy (MDMA-AT) as a potential treatment for posttraumatic stress disorder. The authors focus on U.S. Food and Drug Administration regulatory challenges associated with evaluating MDMA and psychotherapy in conjunction and the role that a risk evaluation in management mitigation program may play in assessing risks and benefits of MDMA-AT. Also discussed are workforce considerations, including foreseeable training requirements, and concerns related to off-label use. The authors emphasize the need for continued research, careful regulation, and thorough clinician education to realize the therapeutic potential of MDMA while ensuring patient safety.

Source: American Journal of Psychiatry Residents Journal

DOI: 10.1176/appi.ajp-rj.2024.200108

Authors: G. Luke Hartstein, Sahit N. Menon

Institutions: Beth Israel Deaconess Medical Center, University of California San Diego

Language: English

Topic: Psychedelics and Drug Studies

Subfield: Clinical Psychology

Field: Psychology

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4402321753

FWCI: 0.954

Cites: 11

Cited by: 2

Related to: 10